Amcor (AMC) might not be anybody’s idea of an exciting stock, but after many years of flat-to-no sales growth we are finally seeing an improvement…
…which is translating into higher earnings.
…and that flows through to forecast eps estimates as well.
It has great free cashflows, for a business that is capital intensive (normally capex heavy business have rubbish returns, and worse fcf).
Margins suggest reasonable pricing power, given the inflationary backdrop.
At a fairly modest valuation.
Not the cheapest, in the sector, but many of the other materials names are over-earning, and you’ve got to be pretty spot on at your war-gaming/scenario analysis as to what premia are priced in, and for how long, across your various commodities.
Now I would not want anyone to think they are immune, from high raw material prices. The stocks recent share price weakness is likely a function over exactly these kinds of concern (polyethylene terephthalate [PET] is hydrocarbons, cans are aluminium, both of which are at sky-high prices), as well as EU exposure given the war.
Momentum is one of the most reliable/powerful/enduring of the factor premia. Most of the time, in a disagreement with the market, one should favour the market.
However, it is a QGARP company, which makes it interesting to us.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.